Internal Medicine, Clinical Cardiatric Electrophysiology · Newport Beach, CA
NPI
1225061591
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 Superior Ave Ste 345
Newport Beach, CA, 92663
Phone (949) 646-1877
Groups this clinician bills Medicare through
Medicare paid, 2024
$539K
6,429 services
Medicare patients, 2024
1,300
Average age 80
Drug cost, 2024
$2.7M
9,215 prescriptions
Company payments, 2025
$1,321
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mahnaz Behboodikhah was code 93000 (electrocardiogram), 1,575 times for 1,083 patients. In total Mahnaz Behboodikhah billed 6,429 services in 72 codes, and Medicare paid $539K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,575 | 1,083 | $11.69 | $18K |
| 99214 Office E&M - Established | Office | 1,203 | 850 | $101.68 | $122K |
| 99215 Office E&M - Established | Office | 567 | 417 | $143.01 | $81K |
| 93306 Echocardiography (TTE/TEE) | Office | 480 | 461 | $166.24 | $80K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 391 | 290 | $13.32 | $5,207 |
| 93294 External Electrocardiographic Monitoring | Office | 248 | 153 | $23.28 | $5,774 |
| 93280 External Electrocardiographic Monitoring | Facility | 180 | 137 | $28.89 | $5,200 |
| 99205 Office E&M - New | Office | 168 | 168 | $172.12 | $29K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 149 | 75 | $76.21 | $11K |
| 93306 Echocardiography (TTE/TEE) | Facility | 107 | 95 | $54.95 | $5,880 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 96 | 24 | $6.17 | $593 |
| 93015 Electrocardiogram | Office | 96 | 95 | $54.52 | $5,234 |
| 78452 Myocardial Perfusion Scan | Office | 91 | 91 | $379.29 | $35K |
| 99233 Hospital E&M - Subsequent | Facility | 83 | 62 | $94.05 | $7,806 |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 50 | $63.30 | $4,810 |
By year: 2022 $626K for 10,044 services; 2023 $597K for 7,624 services; 2024 $539K for 6,429 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mahnaz Behboodikhah prescribed most often to Medicare patients was Metoprolol Succinate, with 1,091 prescriptions and refills. In total Mahnaz Behboodikhah wrote 9,215 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,091 | 3,177 | 345 | $16K |
| Eliquis Apixaban | 878 | 1,901 | 215 | $1.1M |
| Rosuvastatin Calcium Generic | 577 | 1,675 | 180 | $8,410 |
| Amlodipine Besylate Generic | 576 | 1,610 | 191 | $4,499 |
| Xarelto Rivaroxaban | 486 | 1,129 | 125 | $617K |
| Nebivolol Hcl Generic | 422 | 1,109 | 110 | $31K |
| Ezetimibe Generic | 385 | 1,122 | 133 | $13K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 355 | 984 | 128 | $13K |
| Entresto Sacubitril/Valsartan | 320 | 712 | 77 | $355K |
| Furosemide Generic | 271 | 685 | 91 | $1,551 |
| Spironolactone Generic | 265 | 729 | 91 | $2,729 |
| Digoxin Generic | 251 | 730 | 86 | $7,058 |
| Sotalol Af Sotalol Hcl | 232 | 654 | 71 | $9,102 |
| Carvedilol Generic | 223 | 637 | 71 | $2,017 |
| Atorvastatin Calcium Generic | 202 | 576 | 58 | $2,302 |
Brand drugs: 2,231 claims; generic drugs: 6,984 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahnaz Behboodikhah $1,321 ($1,321 in general payments such as food, travel and fees) from 12 companies. The largest payer was Boston Scientific Corporation with $231.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 22 | $231 |
| Medtronic, Inc. MDT | 22 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $207 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $177 |
| Amgen Inc. AMGN | 5 | $103 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $99.72 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $97.31 |
| Esperion Therapeutics, Inc. ESPR | 3 | $68.03 |
| Novo Nordisk Inc NVO | 2 | $55.38 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $34.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.